• SENSEX 76,718.56
    148.21 (+0.19%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    351.60 486.45(%)
  • Netweb Technol.
    5,347.65 5,810.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    101.60 99.45(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Godrej Consumer
    859.50 891.10(%)
  • Max Healthcare
    988.00 903.50(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Solar Industries
    21,569.40 20,760.15(%)
  • Elgi Equipments
    629.30 643.30(%)
  • Energy InfrTrust
    74.25 102.00(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Bharat Dynamics
    1,266.45 1,655.25(%)
  • Jyoti CNC Auto.
    999.00 1,055.00(%)
  • Welspun Corp
    2,675.00 2,593.15(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Anant Raj
    634.60 744.10(%)
  • Coal India
    428.40 490.90(%)
  • RBL Bank
    409.00 397.95(%)
  • Multi Comm. Exc.
    3,180.35 1,496.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amanta Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23748.0
  • ISIN : INE084K01015
186.50 -4 (-1.84%)
  • As on 03 Sep 2026 (EOD)
  • Today’s Low

    186.50
  • Today’s High

    190.00
  • Open

    190.00
  • Perv Close

    190.00
  • 52W Low

    92.00
  • 52W High

    205.57

Key Indicators

  • P/E(TTM)

    47.42

  • Mar.Cap (₹Cr.)

    724.17

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.71

  • Debt-Equity Ratio

    -1.84

  • AGM Date

    02-Sep-2026

  • EPS

    3.95

  • P/E Ratio

    47.42

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    724.17

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    38.83

  • BV (₹)

    56.70

  • Sales( ₹ in Cr.)

    287.68

  • NP (in Cr.)

    16.37

  • NP Var(%)

    55.0

  • Div%

    0.0

  • CPS (₹)

    9.00

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    727.27

  • 52 Week High

    205.57

  • 52 Week Low

    92.00

  • Price BSE

    187.0

  • Price NSE

    187.00

  • Market Capital( in Cr.)

    727.27

  • P/C Ratio

    20.70

  • P/E Ratio

    44.40

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 287.68 274.71 280.34 259.13 225.44 171.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 287.68 274.71 280.34 259.13 225.44 171.29
Other Income 3.37 1.39 1.27 3.57 76.09 1.06
Stock Adjustments 10.89 19.53 -17.31 -0.53 12.29 14.32
Total Income 301.94 295.63 264.30 262.17 313.82 186.67
EXPENDITURE :            
Raw Materials 67.89 76.99 52.82 101.24 89.09 63.84
Power and Fuel Cost 22.93 22.23 24.74 23.36 17.85 14.24
Employee Cost 42.96 36.34 32.55 31.87 39.59 34.43
Other Manufacturing Expenses 64.91 60.36 58.93 36.86 24.20 17.98
Selling and Administration Expenses 35.91 34.52 33.41 9.19 9.99 9.51
Miscellaneous Expenses 6.74 4.12 3.10 3.35 4.96 7.28
Employee Benefit Expenses 42.96 36.34 32.55 31.87 39.59 34.43
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 241.34 234.56 205.54 205.87 185.68 147.27
Operating Profit 60.60 61.06 58.76 56.31 128.15 39.40
Interest 20.75 27.95 33.64 35.27 48.88 40.13
Gross Profit 39.85 33.11 25.12 21.04 79.27 -0.73
Depreciation 18.73 18.40 19.73 18.35 17.34 17.02
Profit Before Tax 21.12 14.71 5.39 2.69 61.93 -17.75
Current Tax 8.59 3.59 4.10 -1.28 6.78 3.77
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.34 0.61 -2.35 6.09 0.04 0.31
Reported Net Profit 14.88 10.50 3.63 -2.11 55.11 -21.83
Extraordinary Items -1.49 -0.07 -0.01 0.00 67.84 0.00
Adjusted Net Profit 16.37 10.57 3.64 -2.11 -12.73 -21.83
Adjustment below Net Profit -0.72 -0.40 -0.23 0.00 -2.03 0.00
P & L Balance brought forward 28.56 16.14 10.82 15.00 -40.71 -18.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 10.00 -2.33 -1.91 2.06 0.00 0.00
P & L Balance carried down 32.71 28.56 16.14 10.82 12.37 -40.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.83 3.64 1.35 -0.79 20.54 -8.14
Earnings Per Share(Adj)-Unit Curr 3.83 - - - - -
Book Value 56.71 33.43 24.71 23.44 23.25 2.71
Book Value(Adj)-Unit Curr 56.71 - - - - -

Shareholding Pattern

  • Promoter Group

    63.80%

  • Public Share Holding

    36.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 14,341,571 14,341,571.00 14,341,571 14,341,571
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 14,341,571 36.93 14,341,571 9
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,100,000 7.98 3,100,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,332,289 18.88 7,332,289 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,432,289 26.87 10,432,289 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 168,463 0.43 168,463 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,067,840 5.33 2,067,840 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,948,087 7.59 2,948,087 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,184,390 13.35 5,184,390 12
2] Non Institution
Bodies Corporate 457,184 1.18 457,184 39
Clearing Members 285,127 0.73 285,127 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 431,693 1.11 431,693 62
Foreign Non Institution Other 300,190 0.77 300,190 1
Hindu Undivided Families 462,096 1.19 462,096 310
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,859,507 7.36 2,246,807 50
Individuals holding nominal share capital up to Rs. 1 lakh 3,917,481 10.09 3,636,419 12,111
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,871,101 22.85 7,977,339 12,586
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 38,829,351 100.00 37,910,426 12,612

Company Background

Amanta Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Amanta Healthcare Ltd
  • BSE Code : 23748.0
  • ISIN : INE084K01015
  • Incorporation Year

    1994

  • Registered Office

    8th Floor Shaligram Corporates
    C.J.Marg Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    079 6777 7600

  • FAX

  • Chairman

    Bhavesh Patel

  • Managing Director

    Bhavesh Patel

  • Company Secretary

    Nikhita Dinodia

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Amanta Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amanta Healthcar 187.30 291.05 287.68 49.55 11.61
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77